Biological barriers are essential physiological protective systems and obstacles to drug delivery. Nanoparticles (NPs) can access the paracellular route of biological barriers, either causing adverse health impacts on humans or producing therapeutic opportunities. This Review introduces the structural and functional influences of NPs on the key components that govern the paracellular route, mainly tight junctions, adherens junctions, and cytoskeletons. Furthermore, we evaluate their interaction mechanisms and address the influencing factors that determine the ability of NPs to open the paracellular route, which provides a better knowledge of how NPs can open the paracellular route in a safer and more controllable way. Finally, we summarize limitations in the research models and methodologies of the existing research in the field and provide future research direction. This Review demonstrates the in-depth causes for the reversible opening or destruction of the integrity of barriers generated by NPs; more importantly, it contributes insights into the design of NP-based medications to boost paracellular drug delivery efficiency.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acsnano.2c05317 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders.
Expert Opin Drug Deliv
December 2024
Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun, PR China.
Introduction: Bacteria and their derivatives show great potential as drug delivery systems due to their unique chemotaxis, biocompatibility, and targeting abilities. In CNS disease treatment, bacterial carriers can cross the blood-brain barrier (BBB) and deliver drugs precisely, overcoming limitations of traditional methods. Advances in genetic engineering, synthetic biology, and nanotechnology have transformed these systems into multifunctional platforms for personalized CNS treatment.
View Article and Find Full Text PDFTranscellular transport of F-deoxyglucose via facilitative glucose channels in experimental peritoneal dialysis.
Perit Dial Int
December 2024
Nephrology Division, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.
Background: Local and systemic side effects of glucose remain major limitations of peritoneal dialysis (PD). Glucose transport during PD is thought to occur via inter-endothelial pathways, but recent results show that phloretin, a general blocker of facilitative glucose channels (glucose transporters [GLUTs]), markedly reduced glucose diffusion capacity indicating that some glucose may be transferred via facilitative glucose channels (GLUTs). Whether such transport mainly occurs into (absorption), or across (trans-cellular) peritoneal cells is as yet unresolved.
View Article and Find Full Text PDFStructure-function analysis of tight junction-directed permeation enhancer PIP250.
J Control Release
October 2023
Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath BA2 7AY, UK. Electronic address:
The intestinal paracellular route of absorption is modulated via tight junction (TJ) structures located at the apical neck of polarized intestinal epithelial cells to restrict solute movement through the intercellular space between them. Tight junctions open or close in response to changes in the phosphorylation status of light chain (MLC) at position Ser-19. This phosphorylation event is primarily controlled by MLC kinase (MLCK) and MLC phosphatase (MLCP), the latter being a holoenzyme that involves interaction between protein phosphatase 1 (PP1) and myosin targeting protein 1 (MYPT1).
View Article and Find Full Text PDFInvolvement of aquaporins in Shiga toxin-induced swelling and water transport dysfunction in human renal microvascular endothelial cells.
Biochim Biophys Acta Mol Cell Res
January 2025
Universidad de Buenos Aires, Facultad de Ciencias Médicas, Departamento de Ciencias Fisiológicas, Laboratorio de Fisiopatogenia, Buenos Aires C1121ABG, Argentina; CONICET - Universidad de Buenos Aires, Instituto de Fisiología y Biofísica Bernardo Houssay (IFIBIO Houssay), Buenos Aires C1121ABG, Argentina. Electronic address:
One of the hallmarks of Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (STEC-HUS) is kidney damage. Our previous research demonstrated that Shiga toxin type 2 (Stx2a) decreases cell viability and induces swelling of human glomerular endothelial cells (HGEC). However, Stx2a can disrupt net water transport across HGEC monolayers without affecting cell viability.
View Article and Find Full Text PDFMechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon.
J Control Release
November 2024
School of Pharmacy, Key Laboratory of Smart Drug Delivery of MOE, Fudan University, Shanghai 201203, China. Electronic address:
Article Synopsis
- Proteins and peptides are being developed as pharmaceuticals due to their effectiveness and fewer side effects, but they usually require injections, which can be inconvenient for patients.
- Choline-based ionic liquids (ILs), like choline geranic acid and choline citric acid, show promise in enhancing the absorption and retention of glucagon when administered nasally, leading to effective treatment for acute hypoglycemia in type 1 diabetic rats without causing rebound hyperglycemia.
- While the continuous nasal application of ILs can cause some temporary safety issues, such as inflammation and changes in cell functions, these effects are reversible thanks to the natural healing abilities of epithelial cells, indicating that ILs could be viable for long-term delivery of large biomolecules
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!